CONSYGEN INC
10QSB, 2000-10-13
PREPACKAGED SOFTWARE
Previous: EQUUS CAPITAL PARTNERS LP, 40-17F2, 2000-10-13
Next: CONSYGEN INC, 10QSB, EX-27, 2000-10-13



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-QSB

              Quarterly report pursuant to Section 13 or 15 (d) of
                      the Securities Exchange Act of 1934

                 For the quarterly period ended August 31, 2000

                          Commission File Number: 17598

                                 CONSYGEN, INC.
             (Exact name of Registrant as specified in its charter)

               Texas                                             76-0260145
  -------------------------------                             ----------------
  (State or other jurisdiction of                             (I.R.S. Employer
   incorporation or organization)                            Identification No.)


 125 South 52nd Street, Tempe, Arizona                             85281
----------------------------------------                         ----------
(Address of principal executive offices)                         (Zip Code)

                                 (480) 394-9100
              ----------------------------------------------------
              (Registrant's telephone number, including area code)


Indicate  by check  mark  whether  the  registrant:  (1) has filed  all  reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant  was  required to file such  reports) Yes [X] No [ ] and (2) has been
subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest practicable date.

34,735,248 shares of Common Stock, $.003 par value, as of October 11, 2000.
<PAGE>
                                 CONSYGEN, INC.

                                      INDEX

PART I   FINANCIAL INFORMATION:

         Item 1. Financial Statements.

                 Consolidated Balance Sheet,
                   August 31, 2000                                             2

                 Consolidated Statements of Operations - Three and Nine
                   Months Ended August 31, 2000 and August 31, 1999            3

                 Consolidated Statements of Cash Flows - Three and Nine
                   Months Ended August 31, 2000 and August 31, 1999            4

                 Notes to Consolidated Financial Statements                    5

         Item 2. Management's Discussion and Analysis of Financial
                   Condition and Results of Operations                         5

PART II  OTHER INFORMATION

         Item 5. Other Information                                             9

         Item 6. Exhibits and Reports on Form 8-K.                             9

                 SIGNATURES                                                   10

                  CAUTION REGARDING FORWARD-LOOKING STATEMENTS

     CERTAIN STATEMENTS  CONTAINED IN THIS REPORT AND IN DOCUMENTS  INCORPORATED
BY REFERENCE HEREIN CONSTITUTE  "FORWARD-LOOKING  STATEMENTS" WITHIN THE MEANING
OF SECTION 27A OF THE  SECURITIES  ACT OF 1933 AND SECTION 21E OF THE SECURITIES
EXCHANGE ACT OF 1934.  FOR THIS  PURPOSE,  ANY  STATEMENTS  CONTAINED  HEREIN OR
INCORPORATED BY REFERENCE  HEREIN THAT ARE NOT STATEMENTS OF HISTORICAL FACT MAY
BE DEEMED TO BE FORWARD-LOOKING STATEMENTS.  WITHOUT LIMITING THE FOREGOING, THE
WORDS "BELIEVES," "PLANS,"  "ANTICIPATES,"  "EXPECTS,"  "ESTIMATES," AND SIMILAR
EXPRESSIONS ARE INTENDED TO IDENTIFY  FORWARD-LOOKING  STATEMENTS.  ALTHOUGH THE
COMPANY BELIEVES THAT THE ASSUMPTIONS ON WHICH SUCH  FORWARD-LOOKING  STATEMENTS
ARE BASED ARE REASONABLE,  THERE CAN BE NO ASSURANCE THAT SUCH  ASSUMPTIONS WILL
PROVE TO BE ACCURATE,  AND ACTUAL  RESULTS  COULD DIFFER  MATERIALLY  FROM THOSE
DISCUSSED  IN  THE  FORWARD-LOOKING  STATEMENTS.   FACTORS  THAT  MAY  CAUSE  OR
CONTRIBUTE TO SUCH DIFFERENCES  INCLUDE, BUT ARE NOT LIMITED TO, THOSE SET FORTH
UNDER THE CAPTION  "MANAGEMENT'S  DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS" AND ELSEWHERE IN THIS REPORT.
<PAGE>
PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

                                 CONSYGEN, INC.
                           CONSOLIDATED BALANCE SHEET

                                     ASSETS
                                                                    August 31,
                                                                       2000
                                                                   ------------
Current Assets:
  Cash and Cash Equivalents                                        $      2,948
  Accounts Receivable                                                    69,287
  Inventory                                                             213,066
  Prepaid Expenses                                                      212,394
  Other Current Assets                                                      708
                                                                   ------------
             Total Current Assets                                       498,403
                                                                   ------------
Property and Equipment - Net                                          1,494,410
                                                                   ------------
Other Assets:
  Debt Issuance Expense                                                  65,275
  Notes receivable                                                       72,725
  Other Assets                                                           44,736

                                                                   ------------
             Total Other Assets                                         182,736
                                                                   ------------
Total Assets                                                       $  2,175,549
                                                                   ============

                 LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

Current Liabilities:
  Accounts Payable                                                 $    319,737
  Notes Payable                                                         871,534
  Capital Lease - Current portion                                        22,127
  Accrued Liabilities                                                 1,277,024

                                                                   ------------
     Total Current Liabilities                                        2,490,422

Convertible Debentures                                                1,186,810
Capital Lease - Long Term Portion                                        29,503
Mortgage - Long Term                                                    532,708
Long-Term Debt                                                          364,829
                                                                   ------------
     Total Liabilities                                                4,604,272
                                                                   ------------
Commitments & Contingencies

Stockholders' Equity :
  Common Stock, $.003 par Value, Authorized
     40,000,000 Shares, Issued and outstanding
     26,323,931 Shares at August 31, 2000                                78,972
  Additional Paid-in Capital                                         32,528,969
  Accumulated Deficit                                               (34,620,940)
  Treasury Stock, at cost (90,000 shares)                              (415,725)
                                                                   ------------
     Total Stockholders' Equity                                      (2,428,723)
                                                                   ------------

Total Liabilities and Stockholders' Equity                         $  2,175,549
                                                                   ============

The accompanying notes are an integral part of the financial statements.

                                       2
<PAGE>
                                 CONSYGEN, INC.
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (UNAUDITED)

                                                        For the Three Months
                                                          Ended August 31,
                                                    ---------------------------
                                                        2000            1999
                                                    ------------   ------------
Counterfeit Cop Revenue                             $    799,574   $     44,503
Software Services Revenue                                     --         73,365
                                                    ------------   ------------
Revenues                                                 799,574        117,868
                                                    ------------   ------------
Costs and Expenses:
  Cost of Sales - Cop                                    199,273          9,243
  Cost of Sales - Software Services                           --        204,683
  Software Development                                   295,540        125,175
  Selling, General and Administrative Expenses           913,298        783,935
  Interest Expense                                       247,198         97,014
  Depreciation and Amortization                           41,861         59,010
                                                    ------------   ------------

      Total Costs and Expenses                         1,697,170      1,279,060
                                                    ------------   ------------

Loss from Operations                                    (897,596)    (1,161,192)

Interest Income                                               --          5,755
Other Income                                             341,711         27,493
Other Expenses                                                --       (287,458)
                                                    ------------   ------------
Net Loss                                            $   (555,885)  $ (1,415,402)
                                                    ============   ============

Weighted Average Common Shares Outstanding            25,257,989     15,416,201
                                                    ============   ============

Net Loss per Common Share                           $      (0.02)  $      (0.09)
                                                    ============   ============

The accompanying notes are an integral part of the financial statements.

                                       3
<PAGE>
                                 CONSYGEN, INC.
                      CONSOLIDATED STATEMENT OF CASH FLOWS
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                                    For the Three Months Ended
                                                                           August 31,
                                                                    --------------------------
                                                                       2000            1999
                                                                    ---------      -----------
<S>                                                                 <C>            <C>
Cash Flows from Operating Activities:
  Net Loss                                                          $(555,885)     $(1,415,403)
  Adjustments to Reconcile Net Loss to
    Net Cash (Used) by Operating Activities:
      Depreciation and amortization                                    41,861           60,585
      Write-off of investment in technology                                --          230,000
      Issuance of stock for professional fees
      Gain on variable stock option awards                           (341,436)
      Changes in Operating Assets and Liabilities:
        Accounts Receivable                                           (19,825)         (40,692)
        Inventories                                                   199,272         (158,081)
        Prepaid Expenses and Other Assets                             237,747             (682)
        Accounts Payable                                              (15,740)         176,227
        Accrued Liabilities                                           179,446          241,904
                                                                    ---------      -----------
           Net Cash (Used) by Operating Activities                   (274,560)        (906,142)
                                                                    ---------      -----------
Cash Flows from Investing Activities:
  Utilization of certificate of deposit for inventory purchases            --          333,944
  Purchase of technology                                                   --         (230,000)
  Advances on note receivable                                         (34,200)
  Purchases of Furniture and Equipment                                (21,843)         (72,497)
  Investment in joint venture                                         (20,000)
                                                                    ---------      -----------
           Net Cash (Used) by Investing Activities                    (76,043)          31,447
                                                                    ---------      -----------
Cash Flows from Financing Activities:
  Proceeds from Sale of Common Stock                                  305,080           14,941
  Payments of principal on loans                                       (4,165)          (3,056)
  Proceeds of Loans payable -- Related Parties                         83,694          147,051
  Proceeds on other notes payable                                          --
  Purchase of treasury stock                                          (15,725)
  Payments of principal on capital lease obligations                  (18,938)         (14,136)
                                                                    ---------      -----------
           Net Cash Provided by Financing Activities                  349,946          144,800
                                                                    ---------      -----------

Net Decrease in Cash and Cash Equivalents                                (657)        (729,895)

Cash and Cash Equivalents  --Beginning of Period                        3,605          739,308
                                                                    ---------      -----------

Cash and Cash Equivalents  --End of Period                          $   2,948      $     9,413
                                                                    =========      ===========
Supplemental Cash Flow Information:
  Cash Paid for Interest                                            $  49,470      $    49,470
                                                                    =========      ===========
Non-Cash Financing and Investing Activities:
  Issuance of Common Stock as Loan Incentive                        $      --      $    20,839
                                                                    =========      ===========

    Conversion of debt to common stock                              $ 651,190      $        --
                                                                    =========      ===========

    Issuance of common stock for prepaid professional fees          $ 287,505      $        --
                                                                    =========      ===========

    Issuance of common stock for equipment                          $ 283,500      $        --
                                                                    =========      ===========
</TABLE>

The accompanying notes are an integral part of the financial statements.

                                       4
<PAGE>
                                 CONSYGEN, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                           August 31, 2000 (Unaudited)

NOTE 1 - BASIS OF PRESENTATION

     The  consolidated  financial  statements  include the accounts of ConSyGen,
Inc., a Texas corporation  ("ConSyGen-Texas")  and its wholly-owned  subsidiary,
ConSyGen,  Inc.,  an  Arizona  corporation   ("ConSyGen-Arizona").   Significant
intercompany accounts and transactions have been eliminated.

     ConSyGen-Texas  and  its  wholly-owned   subsidiary   ConSyGen-Arizona  are
hereafter collectively referred to as the "Company."

     In the opinion of the  Company,  the  accompanying  unaudited  consolidated
financial   statements  reflect  all  adjustments  (which  include  only  normal
recurring adjustments) necessary to present fairly the results of operations and
cash flows for the periods presented.

     Results of operations for interim periods are not necessarily indicative of
the  results of  operations  for a full year due to  external  factors  that are
beyond the control of the Company.

NOTE 2 - STOCKHOLDERS' EQUITY (DEFICIT)

     STOCK OPTIONS

     The Company issued stock options to employees that were later repriced.  In
accordance with APB No. 25, these options are now classified as variable awards.
On the basis of the price of the Company's  common stock at August 31, 2000, the
decrease of $341,000 in the intrinsic  value of those options was  recognized as
other income in the three months ended August 31, 2000.  The Company  intends to
continue to compensate employees with stock options.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        OF OPERATIONS

     The following  discussion and analysis  should be read in conjunction  with
the Company's  Consolidated Financial Statements and the Notes thereto appearing
elsewhere  in  the  Report.   The  Company  and  its  wholly-owned   subsidiary,
ConSyGen-Arizona, are herein collectively referred to as the "Company."

                                       5
<PAGE>
OVERVIEW

     Historically,  we have  developed  pre-packaged  software  and  proprietary
products and services.  However, we have recently moved our specific emphasis to
identifying developing  software-related business opportunities and technologies
and  providing   timely  and  effective   software-based   solutions  for  these
opportunities,  while still maintaining our traditional emphasis on high-quality
proprietary products and services.

     We  are  marketing  the  COUNTERFEIT  COP  through  our  Business  Products
Division.  We have entered into distribution  agreements with third parties with
national  domestic  distribution  networks,  and we have  incorporated  ConSyGen
s.r.o. in the Czech Republic to begin marketing the product in Europe.  Now that
CE certification has been secured,  we expect European sales to begin in the 2nd
quarter.  We intend to continue the active  marketing  of this  product  through
these distribution channels and others that we expect to create in the future.

     We are  completing  the first phase of the  development of the BIZPAY SUITE
software - a new  "e-commerce"  product.  We have  incorporated  a new  company,
BizPay International,  to hold our interests in various BizPay businesses around
the world. We have established a joint venture with an Australian  partner,  and
have signed several  Memorandums of Understanding  (MOU) with strategic partners
to  introduce  the product in Europe,  and several  other  locations  around the
world. Additionally,  we have entered into a MOU with Cardservice International,
a merchant processor, to develop the BizPay business in the United States. These
transactions are subject to definitive agreements.

     Each of these transactions is quite complex, with different revenue models.
Management  is  evaluating  each  opportunity  to  determine  whether  to pursue
licensing  fees, an equity stake in the ongoing  business,  or a combination  of
both as payment for our software.

     With the BizPay suite of products near Phase I completion,  the Counterfeit
Cop division,  and the new multimedia division which we introduced in August, we
will begin segment  reporting in accordance  with SFAS 131. The  Counterfeit Cop
division,  which is currently our only operational division,  earned $197,317 in
the  quarter on  revenues  of  $799,574.  Neither  the BizPay  division  nor the
multimedia  division had any revenue in the quarter  ended  August 31, 2000.  We
continued  to invest in the  development  of both  divisions.  Expenses  for the
BizPay  division  were  $893,889 for the quarter,  and start up expenses for the
multimedia  division  were  $47,048.  Both  divisions  will begin to  contribute
revenue during the current fiscal year.

     We have been involved in material  litigation  with holders (the "Debenture
Holders") of our 6% Convertible  Debentures Due May 29, 2003 (the "Debentures").
In 1998, the Debenture Holders filed a lawsuit against us based upon our failure
to honor  their  requests  to  convert  the  Debentures  to  common  stock  (the
"Debenture  Litigation").  In January  1999,  the  Debenture  Holders  and other
plaintiffs  (together,  the "Plaintiffs")  filed related lawsuits against us and
certain of our former  officers,  and  others,  to recover  damages  for alleged
intentional and calculated  defamation (the "Defamation  Litigation").  On April
11, 2000,  we entered into a definitive  Settlement  Agreement  and  Conditional
Release  with  the  Plaintiffs  to  settle  the  Debenture  Litigation  and  the

                                       6
<PAGE>
Defamation  Litigation.  Provided  that  we  honor  our  obligations  under  the
Settlement  Agreement and the Debentures,  which we intend to do, the settlement
will fully and  finally  resolve the  Debenture  Litigation  and the  Defamation
Litigation. Under the Settlement Agreement, we have agreed to honor the terms of
the Debentures  (and the related common stock purchase  warrants) and to convert
the principal and accrued  interest on the  Debentures  into our common stock as
the  Debenture  Holders  request  such  conversion  and as  permitted  under the
Debentures.  As  of  August  31,  2000,  and  October  10,  2000,  approximately
$2,241,000 and $2,663,000 respectively in principal amount of the Debentures has
been converted into shares of our common stock in partial  implementation of the
settlement. In addition, we have agreed to pay (in common stock, to be issued as
the  Debentures  are  converted) an additional  $350,000 in liquidated  damages,
which  amount was accrued in the third  quarter of the year ending May 31, 2000.
We  have  agreed  to  perform  additional  non-monetary  obligations  under  the
Settlement   Agreement  which,  while  they  represent  material  terms  of  the
Settlement  Agreement and Conditional  Release,  we believe we can  successfully
perform without a material adverse financial impact.

     We are involved in litigation  with a former officer and director  relating
to his  claims  for  indemnification  and  reimbursement  of legal  expenses  in
connection  with the  Defamation  Litigation,  and for  breach of an  employment
agreement with respect to stock  options.  The former  executive  seeks damages,
including  substantial exemplary and punitive damages, and an order requiring us
to  honor  stock  options.  Although  we  believe  that  the  settlement  of the
Defamation  Litigation  mitigates  potential  damages  in this  litigation,  the
outcome of this litigation,  and its potential financial impact on us, cannot be
estimated fully at this time.  However, at the present time, we believe that the
claims for  exemplary  and punitive  damages  relating to both the indemnity and
stock option claims are wholly without merit.

     We are involved in litigation  with a former  customer who has alleged that
we breached an agreement to provide software conversion services and to test its
software  for the ability to  function  in the year 2000 and  beyond.  While the
lawsuit seeks a substantial  amount of damages,  we intend to defend this action
vigorously and to assert set-offs and  counterclaims in these  proceedings.  The
outcome and potential  financial  impact of this  litigation on us cannot yet be
estimated.

MATERIAL CHANGES IN RESULTS OF OPERATIONS

     NET LOSSES.  For the three months ended August 31, 2000,  we incurred a net
loss of approximately  $555,885,  compared with a net loss of $1,415,402 for the
three months ended August 31,  1999, a decrease of  approximately  $859,517.  An
explanation of these losses is set forth below.

     REVENUE.  For the  quarter  ended  August  31,  2000,  we had  revenues  of
$799,574,  compared to $44,503 for the same  quarter in the previous  year.  The
increase in revenue  reflects  growth in revenues from sales of the  COUNTERFEIT
COP product. Although Counterfeit Cop revenue for the quarter grew approximately
1800% from the same  quarter a year ago,  our master  distributors  have not yet
significantly contributed to the revenue growth.

                                       7
<PAGE>
     COST OF SALES.  For the quarter ended August 31, 2000,  the primary cost of
sales expense is the cost of obtaining  COUNTERFEIT COP units from our supplier.
These costs represent approximately 25% of related revenue.

     SOFTWARE  RESEARCH AND DEVELOPMENT  EXPENSES.  For the quarter ended August
31, 2000, software  development  expenses were $295,540,  compared with $125,175
for the comparable prior period. The increase in software  development  expenses
represents  the  large  investment  we made  in the  development  of the  BizPay
product. We have added staff with specialized skills where appropriate, and have
used  consultants as needed.  As we proceed  through beta  testing,  the initial
product roll out, and the development of subsequent phases of BizPay,  including
the wireless  applications,  we do not expect a significant decrease in software
development   expenses.   We  intend  to  begin  capitalizing  certain  software
development costs when proprietary software products have reached  technological
feasibility.

     SELLING,  GENERAL  AND  ADMINISTRATIVE   EXPENSES.   Selling,  general  and
administrative  expenses  were  $913,298 for the quarter  ended August 31, 2000,
compared  with  $785,935  for the  identical  quarter in the previous  year,  an
increase  of  $127,363.  The  increase in  selling,  general and  administrative
expenses is primarily  attributable to increased expenses related to the sale of
the  Counterfeit  Cop,  and the creation of the BizPay and  multimedia  business
lines.  We have been working with our  Counterfeit  Cop master  distributors  to
create  marketing  materials and train their alliance  partners and salespeople,
including at least a half dozen on site training sessions. We made an investment
to obtain CE registration  for the Counterfeit Cop product,  which will allow us
to market the product in Europe and other areas.

     INTEREST  EXPENSE.  For the three months  ended  August 31, 2000,  interest
expense was $247,198, compared with $97,014 for the same quarter in the previous
year,  an increase of $150,184.  The  increase in interest  expense is primarily
composed of $153,702 of accelerated amortization of deferred financing costs due
to conversion of the debentures.

     DEPRECIATION  AND  AMORTIZATION  EXPENSE.  For the quarter ended August 31,
2000,  depreciation and amortization expense was $41,861,  compared with $59,010
for the  previous  year.  The  decrease  indicates  that there has been no major
growth in depreciable  items,  primarily due to a shortage of operating capital.
As we have retired some depreciable assets, we have primarily replaced them with
leased assets. Additionally, the development of the BizPay products has required
an  investment  in  hardware  and  software.  For the most part,  the  necessary
equipment has been leased at prevailing market rates.

     OTHER  INCOME.  Other  Income was $341,711 in the three months ended August
31, 2000, compared to $27,493 in the corresponding quarter of the previous year.
We  re-priced  numerous  options  granted to employees in the year ended May 31,
1999.  Under the Proposed  Interpretation,  ACCOUNTING FOR CERTAIN  TRANSACTIONS
INVOLVING STOCK COMPENSATION, AN INTERPRETATION OF APB OPINION NO. 25, issued by

                                       8
<PAGE>
the Financial  Accounting Standards Board, these constitute variable awards that
require  us  to  recognize   other  income  if  the  stock  price  declines  and
compensation  expense if it  increases.  The price of our  common  stock has not
recently been higher than the re-priced  exercise  price of these  options.  The
income is a direct result of the decline in our stock price.

MATERIAL CHANGES IN FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

     The  Company  has  continued  to suffer  material  operating  losses and is
experiencing  difficulties  meeting its current  obligations,  including regular
payroll  obligations.  Although  revenue has  increased  substantially,  current
revenue  levels are still  inadequate to meet all of the company's  obligations.
The Company is attempting to raise sufficient equity capital to meet its current
obligations  and to implement its new business  plan.  However,  the Company has
experienced difficulty in doing so and there can be no assurance that it will be
successful in raising capital or implementing its new business plan.

     The Company has utilized  significant  resources  in software  development,
research and marketing  efforts.  The investment in the Bizpay  technology alone
was over  $893,000.  Those  efforts must continue in order for the Company to be
successful in the  implementation  of its new strategic  direction.  The Company
will require additional  capital,  most likely from private placement equity, in
order to meet its obligations and to implement its new strategic direction.

     As of August 31, 2000, the Company had $2,900 in cash and cash  equivalents
compared  with  approximately  $3,600 at May 31,  1999.  The Company had working
capital deficit of approximately  $1,992,000 at August 31, 2000, compared with a
working capital deficit of approximately  $2,298,000 at May 31, 2000, a decrease
in working capital deficit of  approximately  $306,000.  The increase in working
capital  is  primarily  attributable  to the draw  down of our  Counterfeit  Cop
inventory  as sales have  increased.  The  Company  had  convertible  debentures
outstanding of $1,838,000 and $1,259,000 at May 31, 2000 and at August 31, 2000.

     Although the Counterfeit Cop division was profitable, The Company continued
to incur losses due to the ongoing  development  of Bizpay and the  formation of
the Multimedia division. During the quarter ended August 31, 2000, the Company's
operations  used  approximately  $274,000 in cash,  an average of  approximately
$91,000 per month. If the Company  continues to incur  significant  losses,  the
Company's liquidity could be materially and adversely affected. The Company does
not currently have any  established  bank credit  facility,  and there can be no
assurance that the Company will be able to obtain the additional  capital in the
form of debt or equity  financing  necessary  to continue its  operations  if no
significant sales are realized.  The Company does not intend to require material
capital expenditures in the short term. However, as discussed above, the Company
will require cash to implement its new strategic direction.

IMPACT OF INFLATION

     Increases in the  inflation  rate are not expected to effect the  Company's
operating  expenses.  Although  the  Company  has no  current  plans  to  borrow
additional  funds, if it were to do so at variable  interest rates, any increase
in interest rates would increase the Company's borrowed funds.

SEASONALITY

     Our operations are not affected by seasonal fluctuations, although our cash
flows may at times be affected by  fluctuations  in the timing of cash  receipts
from large  contracts.  Management  believes that the cash-flow of the two major
product  lines in our new  strategic  direction  will not be  impacted  by large
purchases or seasonal factors.

                          PART II -- OTHER INFORMATION

ITEM 5. OTHER INFORMATION.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

(a)  Exhibits.

     The list of Exhibits  which are filed with this report or  incorporated  by
reference  herein is set forth in the Exhibit  Index that appears  following the
signature page, which Exhibit Index is incorporated herein by this reference.

(b)  Reports on Form 8-K.

     The  Company  filed form 8-K on  12/30/98,  which  reported a legal  action
against the  Company,  on  December 3, 1998,  for  specific  performance  of the
provisions  of the  Debentures  which  permit the  holders  to convert  the debt
evidenced  by the  debentures  into shares of the  Company's  common  stock.  On
December  28, 1998,  the Company  filed an answer in that action  denying  that,
under the pertinent  circumstances,  the Company is obligated to effect any such
conversion.  The Company also filed a counterclaim  against the holders, and new
claims against certain agents of the holders, in the same action,  alleging that
the holders and the agents made material  misrepresentations  in connection with
the purchase and sale of the  Debentures  and made  unlawful  short sales of the
Company's common stock. The Company filed form 8-K on March 22, 2000,  detailing
the settlement term sheet agreed to with the debenture holders.

                                       9
<PAGE>
                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                        CONSYGEN, INC.

Date: October 12, 2000                  By: /s/ A. Lewis Burridge
                                            ------------------------------------
                                            A. Lewis Burridge, President
                                            (Principal Executive Officer)

                                       10
<PAGE>
                                 EXHIBIT INDEX

    2          Plan of Acquisition  between the Registrant and the  stockholders
               of ConSyGen, Inc., an Arizona corporation, dated August 28, 1996,
               filed as Exhibit 2 to the Registrant's Current Report on Form 8-K
               dated September 5, 1996 and incorporated herein by reference.

    3.1        Articles of Incorporation of the Registrant, as amended. (1)

    3.2        Amended and Restated By-Laws of the Registrant. (4)

    4.1        Specimen  common stock  certificate,  filed as Exhibit 4.B to the
               Registrant's  Registration  Statement  on  Form  S-18,  File  No.
               33-22900 - FW, and incorporated herein by reference.

    4.2        Form of Common Stock  Purchase  Warrant used in  connection  with
               issuance of warrants to purchase an aggregate of 1,000,000 shares
               of the Registrant's Common Stock, $.003 par value. (2)

    4.3        Subscription  Agreement used in connection with the Rule 506 sale
               of Convertible  Debentures in the aggregate  principal  amount of
               $3,500,000  (including  form of  Convertible  Debenture,  form of
               Warrant,  and form of Registration Rights Agreement,  attached as
               Exhibits  A,  B  and  D,   respectively,   to  the   Subscription
               Agreement). (6)

    4.4        Form of Common Stock Purchase Warrant to purchase an aggregate of
               10,000  shares  issued in  partial  payment of  finders'  fees in
               connection  with  sale of  Convertible  Debentures  in  aggregate
               principal amount of $3,500,000. (6)

    4.5        Form of  Subscription  Agreement used in connection with Rule 506
               sale of 120,000 shares for gross proceeds of $1,080,000. (1)

    4.6        Form of  Subscription  Agreement used in connection with Rule 506
               sale of 152,000 shares for gross proceeds of $882,500. (1)

    4.7        Form of Common Stock Purchase  Warrant to purchase 200,000 shares
               issued to consultant, Howard R. Baer, on August 1, 1997. (1)

    4.8        Form of Common Stock Purchase  Warrant to purchase 100,000 shares
               issued to Howard R. Baer's designee,  Kevin C. Baer, on August 1,
               1997. (1)

    4.9        Subscription  Agreement used in connection  with Rule 506 sale of
               900,000 shares for gross proceeds of $5,276,250. (3)

    4.10       Form of  Subscription  Agreement used in connection with issuance
               of 30,747  shares in payment  of  indebtedness  in the  aggregate
               amount of $250,575. (3)

    4.11       Common Stock Purchase  Warrant to purchase  100,000 shares issued
               to a consultant's designee,  Irvington  International Limited, as
               of November 10, 1997. (3)

    4.12       Agreement  dated as of July 17, 1998 between the  Registrant  and
               Tom S.  Dreaper  relating to  employment  and grant of options to
               purchase 1,000,000 shares of common stock of the Registrant. (6)

    4.13       Agreement  entitled  "Transfer  of  Complete  Rights in  Software
               Program  between  ConSyGen,  Inc. and F&M  Investments,  L.L.C.",
               filed as Exhibit 4.13 to the Registrant's  Current Report on Form
               8-K dated July 2, 1999 and incorporated herein by reference.
<PAGE>
    4.14       Amendment  dated August 13,  1998,  to 6%  Convertible  Debenture
               Subscription  Agreement and related Registration Rights Agreement
               dated May 29,  1998,  filed as Exhibit  4.13 to the  Registrant's
               Registration  Statement  on Form  S-3,  File No.  333-61869,  and
               incorporated herein by reference.

    4.15       Form of  Subscription  Agreement used in connection  with private
               placement  of  4,498,000  units,  consisting  of one share of the
               Registrant's  common stock and a warrant to purchase one share of
               common stock, for total cash consideration of $1,124,500.

    4.16       Form of Common Stock  Purchase  Warrant used in  connection  with
               issuance of warrants to purchase an aggregate of 4,498,000 shares
               of Registrant's Common Stock, $0.003 par value.

    4.17       Option Agreement for 1,000,000 shares of the Registrant's  common
               stock,  dated April 17,  2000,  issued to  consultant,  Howard R.
               Baer.

    10.7       Registrant's 1996 Non-Qualified Stock Option Plan. (2)

    10.8       Registrant's Second Amended and Restated 1997 Non-Qualified Stock
               Option Plan. (8)

    10.9       Consulting  Agreement  between the Registrant and M.H. Meyerson &
               Co., Inc. dated August 19, 1996. (5)

    10.10      Form of Indemnification  Contract between the Registrant and each
               executive officer and director of the Registrant. (3)

    10.11      Agreement  between the  Registrant  and Carriage  House  Capital,
               Inc., effective as of September 1, 1997, terminating all existing
               agreements  between the  Registrant  and Carriage  House Capital,
               Inc., and its affiliates. (3)

    10.12      Registrant's Form of Settlement Term Sheet between the Registrant
               and the Debenture Parties (Thomson Kernaghan, et al). (7)

    10.13      Settlement   Agreement  and   Conditional   Release  between  the
               Registrant and the Debenture Parties dated April 20, 2000. (9)


    10.14      Agreement  between the  Registrant  and Saviar and Spaeth,  dated
               January 11, 2000.

    16         Letter  dated  September  24,  1998  from  Wolinetz,  Gottlieb  &
               Lafazan, P.C. to the Securities and Exchange Commission, filed as
               Exhibit 16 to the  Registrant's  Current Report on Form 8-K dated
               September 22, 1998 and incorporated herein by reference.

    21         List of Subsidiaries of the Registrant. (9)

    99.1       Registrant's 2000 Combination Stock Option Plan. (10)

----------
*    Filed herewith.

(1)  Filed as an Exhibit,  with the same  Exhibit  number,  to the  Registrant's
     Quarterly  Report on Form 10-Q for the quarter  ended August 31, 1997,  and
     incorporated herein by reference.
<PAGE>
(2)  Filed as an Exhibit,  with the same  Exhibit  number,  to the  Registrant's
     Quarterly  Report on Form 10-Q for the quarter  ended August 31, 1996,  and
     incorporated herein by reference.

(3)  Filed as an Exhibit,  with the same  Exhibit  number,  to the  Registrant's
     Registration  Statement on Form S-1, File No.  333-40649,  and incorporated
     herein by reference.

(4)  Filed as an Exhibit,  with the same  Exhibit  number,  to the  Registrant's
     Quarterly  Report on Form 10-Q for the quarter ended February 28, 1998, and
     incorporated herein by reference.

(5)  Filed as Exhibit No. 10.10 to the  Registrant's  Annual Report on Form 10-K
     for the year ended May 31, 1997, and incorporated herein by reference.

(6)  Filed as an Exhibit,  with the same  Exhibit  number,  to the  Registrant's
     Annual  Report  on  Form  10-K  for  the  year  ended  May  31,  1998,  and
     incorporated herein by reference.

(7)  Filed as an Exhibit,  with the same  Exhibit  number,  to the  Registrant's
     Annual Report on Form 8-K dated March 22, 2000, and incorporated  herein by
     reference.

(8)  Filed as an Exhibit,  with the same  Exhibit  number,  to the  Registrant's
     Quarterly  Report on Form 10-Q for the quarter  ended August 31, 1998,  and
     incorporated herein by reference.

(9)  Filed as an Exhibit,  with the same  Exhibit  number,  to the  Registrant's
     Annual  Report  on Form  10-KSB  for the  year  ended  May  31,  2000,  and
     incorporated herein by reference.

(10) Filed as an Exhibit,  with the same  Exhibit  number,  to the  Registrant's
     Registration  Statement on Form S-8,  dated May 4, 2000,  and  incorporated
     herein by reference.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission